# Max Healthcare Institute Ltd (MAXHEALTH)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹1091.1
Day Change: +1.43%
52W High: ₹1314.3
52W Low: ₹903.5
Market Cap: ₹1,02,191 Cr

## Valuation
P/E: 72.46
P/B: 10.22
EPS: ₹14.49
Book Value: ₹102.71
Dividend Yield: 0%

## Returns
1Y Return: -4.83%

## Profitability
ROE: 0%
ROCE: 24.51%
Debt/Equity: 0.33
Revenue Growth: 10.7%
Profit Growth: 26.6%
EBITDA Margin: 26.27%
Operating Margin: 20.66%

## About
Max Healthcare is a leading Indian company in the Pharmaceuticals space, listed on the NSE. The company is a key player in the Pharma — Formulations segment with a strong market position and diversified operations.
Sector: Pharma
Industry: Medical Care Facilities
Sub Industry: Pharma — Formulations

## Business Model
Overview: Max Healthcare Institute Ltd makes money through Core Business, Other Segments, Exports in Pharma — Formulations. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Core Business
- Other Segments
- Exports
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Business Segments:
- Core Business: 69% of tracked revenue, equal to ₹21,144 Cr. | 69% | ₹21,144 Cr
- Other Segments: 32% of tracked revenue, equal to ₹9,806 Cr. | 32% | ₹9,806 Cr
- Exports: -1% of tracked revenue, equal to ₹-306 Cr. | -1% | ₹-306 Cr
Recent Context:
- Announcement: Construction Of Phase-I Of Max Super Specialty Hospital, Shaheed Path, Lucknow
- Announcement: Approval Of Re-Classification Of Radiant Life Care Hospital Foundation From Promoter Group To Public Category
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

## Access
Current tier: anonymous
More history: Register free to see 6 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:03.547Z
Price History Updated: 2026-05-17T21:29:47.738Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:29:47.738Z
Quant Updated: 2026-05-17T21:29:47.738Z
Sentiment Updated: 2026-05-17T21:29:47.738Z
Financials Status: current
Financials Updated: 2026-05-18T02:53:23.069Z
Financials Last Attempt: 2026-05-18T02:53:23.069Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2018)
Revenue: ₹1608 Cr
Operating Profit: ₹141 Cr (OPM 9%)
Net Profit: ₹16 Cr
Tax: ₹5 Cr

## Annual P&L History
Mar 2018: Rev ₹1608Cr | PAT ₹16Cr | OPM 9%
Mar 2019: Rev ₹1729Cr | PAT ₹-25Cr | OPM 7%
Mar 2020: Rev ₹1691Cr | PAT ₹0Cr | OPM 9%

## Balance Sheet (Mar 2018)
Total Assets: ₹3146 Cr
Total Liabilities: ₹3146 Cr
Borrowings: ₹874 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Abhay  Soi, Executive Chairman & MD
- Yogesh Kumar Sareen, Senior Director & CFO
- Dhiraj  Aroraa, Senior VP, Company Secretary & Compliance Officer
- Prashant  Singh, Director of Information Technology & Chief Information Officer
- Gagan  Palta, General Counsel & Director

## Highlights
- Strong revenue growth of 10% CAGR over 5 years
- ROE of 15.0% indicates efficient capital allocation

## Concerns
- Debt-to-equity ratio needs monitoring amid expansion plans
- Promoter holding has seen slight decline in recent quarters

---
Source: rupiya.io/stocks/maxhealth
Disclaimer: For research and education only. Not investment advice.